Melanie Chan

2.0k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Melanie Chan is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Clinical Psychology. According to data from OpenAlex, Melanie Chan has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Clinical Psychology. Recurrent topics in Melanie Chan's work include Sexual function and dysfunction studies (11 papers), Hormonal and reproductive studies (8 papers) and Sexuality, Behavior, and Technology (7 papers). Melanie Chan is often cited by papers focused on Sexual function and dysfunction studies (11 papers), Hormonal and reproductive studies (8 papers) and Sexuality, Behavior, and Technology (7 papers). Melanie Chan collaborates with scholars based in United States, Canada and United Kingdom. Melanie Chan's co-authors include Anthony Beardsworth, Bruce H. Brundage, Hossein Ardeschir Ghofrani, Nazzareno Galiè, Robyn J. Barst, Gérald Simonneau, Shelley Shapiro, R. James White, Zeenat Safdar and Lyn R. Frumkin and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Melanie Chan

19 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tadalafil Therapy for Pulmonary Arterial Hypertension

2009 794 citations Nazzareno Galiè, Bruce H. Brundage et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melanie Chan United States	12	853	630	454	255	224	19	1.5k
Anthony Beardsworth United States	16	1.0k 1.2×	737 1.2×	203 0.4×	131 0.5×	315 1.4×	20	1.5k
Linda Webster Canada	10	1.2k 1.5×	944 1.5×	104 0.2×	455 1.8×	146 0.7×	12	1.8k
Harbajan Chadha‐Boreham Switzerland	16	712 0.8×	204 0.3×	139 0.3×	177 0.7×	112 0.5×	23	1.6k
Blánaid Hicks United Kingdom	18	337 0.4×	161 0.3×	202 0.4×	182 0.7×	115 0.5×	41	1.1k
Lars Videbæk Denmark	27	323 0.4×	1.5k 2.4×	674 1.5×	363 1.4×	32 0.1×	81	2.2k
F Lamotte France	6	123 0.1×	733 1.2×	509 1.1×	143 0.6×	31 0.1×	10	1.2k
Qiu‐Ting Dong China	22	88 0.1×	542 0.9×	402 0.9×	227 0.9×	23 0.1×	56	1.4k
A. Algra Netherlands	11	297 0.3×	261 0.4×	53 0.1×	144 0.6×	127 0.6×	24	1.3k
Lukas Makris United States	15	208 0.2×	454 0.7×	169 0.4×	105 0.4×	69 0.3×	64	1.0k
Donald L. Akers United States	14	282 0.3×	242 0.4×	126 0.3×	110 0.4×	121 0.5×	33	766

Countries citing papers authored by Melanie Chan

Since Specialization

Citations

This map shows the geographic impact of Melanie Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Chan more than expected).

Fields of papers citing papers by Melanie Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Chan. The network helps show where Melanie Chan may publish in the future.

Co-authorship network of co-authors of Melanie Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie Chan. A scholar is included among the top collaborators of Melanie Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie Chan. Melanie Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Chan, Melanie, et al.. (2024). Measuring Embodied Carbon of Buildings: A Review of Methodologies and Benchmarking Towards Net Zero. IOP Conference Series Earth and Environmental Science. 1363(1). 12030–12030. 3 indexed citations

Payne, Christopher D., Mark A. Deeg, Melanie Chan, et al.. (2014). Pharmacokinetics and pharmacodynamics of the cathepsin S inhibitor, LY3000328, in healthy subjects. British Journal of Clinical Pharmacology. 78(6). 1334–1342. 31 indexed citations

Longhurst, Chris, et al.. (2013). Using an Evidence-Based Approach to EMR Implementation to Optimize Outcomes and Avoid Unintended Consequences.. PubMed. 27(3). 79–83. 4 indexed citations

Oudiz, Ronald J., Bruce H. Brundage, Nazzareno Galiè, et al.. (2012). Tadalafil for the Treatment of Pulmonary Arterial Hypertension. Journal of the American College of Cardiology. 60(8). 768–774. 103 indexed citations

Russell‐Jones, David, Robert Cuddihy, M Hanefeld, et al.. (2011). Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4). Diabetes Care. 35(2). 252–258. 296 indexed citations

Galiè, Nazzareno, Bruce H. Brundage, Hossein Ardeschir Ghofrani, et al.. (2009). Tadalafil Therapy for Pulmonary Arterial Hypertension. Circulation. 119(22). 2894–2903. 794 indexed citations breakdown →

Pepke‐Żaba, Joanna, et al.. (2009). Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension. Current Medical Research and Opinion. 25(10). 2479–2485. 36 indexed citations

Barst, Robyn J., Bruce H. Brundage, Hossein Ardeschir Ghofrani, et al.. (2008). TADALAFIL IMPROVES EXERCISE CAPACITY, HEALTH RELATED QUALITY OF LIFE AND DELAYS TIME TO CLINICAL WORSENING IN PATIENTS WITH SYMPTOMATIC PULMONARY ARTERIAL HYPERTENSION (PAH). CHEST Journal. 134(4). 39S–39S. 2 indexed citations

Eardley, Ian, Francesco Montorsi, Graham Jackson, et al.. (2007). Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open‐label, crossover study. British Journal of Urology. 100(1). 122–129. 30 indexed citations

10.

Kloner, Robert A., Graham Jackson, Adolph M. Hutter, et al.. (2006). Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing. The American Journal of Cardiology. 97(12). 1778–1784. 46 indexed citations

11.

Jc, Lee, Peter Pommerville, Gerald Brock, et al.. (2006). Physician‐rated patient preference and patient‐ and partner‐rated preference for tadalafil or sildenafil citrate: results from the Canadian ‘Treatment of Erectile Dysfunction’ observational study. British Journal of Urology. 98(3). 623–629. 16 indexed citations

12.

Brock, Gerald, John Chan, Serge Carrier, et al.. (2006). The Treatment of Erectile Dysfunction study: focus on treatment satisfaction of patients and partners. British Journal of Urology. 99(2). 376–382. 18 indexed citations

13.

Guo, Ying, Qiang Ding, Edwin Choon Wyn Lim, et al.. (2006). Efficacy and safety of on‐demand tadalafil for the treatment of erectile dysfunction in South‐East Asian men. International Journal of Urology. 13(6). 721–727. 15 indexed citations

14.

Martín‐Morales, Antonio, et al.. (2006). Eficacia y seguridad de Tadalafilo en dos regímenes de dosificación diferentes en pacientes españoles con disfunción eréctil: Resultados procedentes del estudio SURE realizado en 14 países europeos. Actas Urológicas Españolas. 30(8). 791–800. 2 indexed citations

15.

Wespes, Eric, Ignacio Moncada, Henry Schmitt, et al.. (2006). The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study. British Journal of Urology. 99(1). 121–126. 5 indexed citations

16.

Buvat, Irène, et al.. (2006). Efficacy and Safety of Two Dosing Regimens of Tadalafil and Patterns of Sexual Activity in Men with Diabetes Mellitus and Erectile Dysfunction: Scheduled Use vs. On-Demand Regimen Evaluation (SURE) Study in 14 European Countries. The Journal of Sexual Medicine. 3(3). 512–520. 29 indexed citations

17.

Mirone, Vincenzo, P. Costa, Jan‐Erik Damber, et al.. (2005). An Evaluation of an Alternative Dosing Regimen with Tadalafil, 3 Times/Week, for Men with Erectile Dysfunction: SURE Study in 14 European Countries. European Urology. 47(6). 846–854. 51 indexed citations

18.

Moncada, Ignacio, Jan‐Erik Damber, Vincenzo Mirone, et al.. (2005). Sexual Intercourse Attempt Patterns with Two Dosing Regimens of Tadalafil in Men with Erectile Dysfunction: Results from the SURE Study in 14 European Countries. The Journal of Sexual Medicine. 2(5). 668–674. 11 indexed citations

19.

Mirone, Vincenzo, et al.. (2004). 406 Efficacy and safety of two dosing regimens with Tadalafil in men with erectile dysfunction: Results from the sure study in 14 European countries. European Urology Supplements. 3(2). 104–104. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact